COMBI — Combigene AB Balance Sheet
0.000.00%
- SEK50.10m
- -SEK23.65m
- SEK0.33m
Annual balance sheet for Combigene AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | — | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 48.9 | 137 | 132 | 101 | 73.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.958 | 0.686 | 5.61 | 0.725 | 1.37 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 55.4 | 145 | 139 | 103 | 75.1 |
Net Property, Plant And Equipment | — | — | — | 0.851 | 0.675 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 79.4 | 166 | 158 | 121 | 75.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.98 | 7.94 | 6.1 | 4.16 | 4.3 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 7.98 | 7.94 | 6.1 | 4.16 | 4.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 71.4 | 158 | 152 | 116 | 71.6 |
Total Liabilities & Shareholders' Equity | 79.4 | 166 | 158 | 121 | 75.9 |
Total Common Shares Outstanding |